Sghirlanzoni A - Search Results

1

Efficacy of intranasal administration of neostigmine in myasthenic patients.

Sghirlanzoni A, Pareyson D, Benvenuti C, Cei G, Cosi V, Lombardi M, Nicora M, Ricciardi R, Cornelio F. Sghirlanzoni A, et al. J Neurol. 1992 Mar;239(3):165-9. doi: 10.1007/BF00833919. J Neurol. 1992. PMID: 1573422 Clinical Trial.

2

A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy.

Mantegazza R, Beghi E, Pareyson D, Antozzi C, Peluchetti D, Sghirlanzoni A, Cosi V, Lombardi M, Piccolo G, Tonali P, et al. Mantegazza R, et al. Among authors: sghirlanzoni a. J Neurol. 1990 Oct;237(6):339-44. doi: 10.1007/BF00315656. J Neurol. 1990. PMID: 2277266 Clinical Trial.

3

Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis.

Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F. Mantegazza R, et al. Among authors: sghirlanzoni a. J Neurol. 1988 Nov;235(8):449-53. doi: 10.1007/BF00314245. J Neurol. 1988. PMID: 3062134 Clinical Trial.

4

Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.

Ricciardi R, Rossi B, Nicora M, Sghirlanzoni A, Muratorio A. Ricciardi R, et al. Among authors: sghirlanzoni a. J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1061-2. doi: 10.1136/jnnp.54.12.1061. J Neurol Neurosurg Psychiatry. 1991. PMID: 1783916 Free PMC article.

5

Neurophysiological diagnosis of acquired sensory ganglionopathies.

Lauria G, Pareyson D, Sghirlanzoni A. Lauria G, et al. Among authors: sghirlanzoni a. Eur Neurol. 2003;50(3):146-52. doi: 10.1159/000073055. Eur Neurol. 2003. PMID: 14530620

6

Sensory neuron diseases.

Sghirlanzoni A, Pareyson D, Lauria G. Sghirlanzoni A, et al. Lancet Neurol. 2005 Jun;4(6):349-61. doi: 10.1016/S1474-4422(05)70096-X. Lancet Neurol. 2005. PMID: 15907739 Review.

7

Phenotypic heterogeneity in hereditary neuropathy with liability to pressure palsies associated with chromosome 17p11.2-12 deletion.

Pareyson D, Scaioli V, Taroni F, Botti S, Lorenzetti D, Solari A, Ciano C, Sghirlanzoni A. Pareyson D, et al. Among authors: sghirlanzoni a. Neurology. 1996 Apr;46(4):1133-7. doi: 10.1212/wnl.46.4.1133. Neurology. 1996. PMID: 8780105

8

Clinical and magnetic resonance imaging findings in chronic sensory ganglionopathies.

Lauria G, Pareyson D, Grisoli M, Sghirlanzoni A. Lauria G, et al. Among authors: sghirlanzoni a. Ann Neurol. 2000 Jan;47(1):104-9. Ann Neurol. 2000. PMID: 10632108

9

Partial laminin alpha2 chain deficiency in a patient with myopathy resembling inclusion body myositis.

Di Blasi C, Mora M, Pareyson D, Farina L, Sghirlanzoni A, Vignier N, Blasevich F, Cornelio F, Guicheney P, Morandi L. Di Blasi C, et al. Among authors: sghirlanzoni a. Ann Neurol. 2000 Jun;47(6):811-6. Ann Neurol. 2000. PMID: 10852549

10

Neurogenic muscle hypertrophy. Report of two cases.

Pareyson D, Morandi L, Scaioli V, Marazzi R, Boiardi A, Sghirlanzoni A. Pareyson D, et al. Among authors: sghirlanzoni a. J Neurol. 1989 Jul;236(5):292-5. doi: 10.1007/BF00314459. J Neurol. 1989. PMID: 2760647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters